Activating mutations in c-KIT and PDGFRa are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes

Herman Burger, MA den Bakker, J.M. Kros, H Tol, AM de Bruin, Wolter Oosterhuis, HFGM van den Ingh, E (Erwin) van der Harst, HP de Schipper, Erik Wiemer, K (Kees) Nooter

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1270-1274
Number of pages5
JournalCancer Biology & Therapy
Issue number11
Publication statusPublished - 2005

Cite this